According to 24 Chemical Research, the global De-Glycyrrhizic Acid Licorice Extract (DGL) Market was valued at USD 19.00 million in 2025 and is estimated to reach USD 19.86 million in 2026, before expanding to USD 28.24 million by 2034, representing a CAGR of 4.5% during 2026–2034. DGL is produced from Glycyrrhiza species through processing that substantially reduces glycyrrhizin while retaining other licorice constituents. The market focuses on standardized low-glycyrrhizin extracts supplied for food, nutraceutical and pharmaceutical applications.
View the complete report as it is proper:
What’s Driving the Market
- Digestive-health demand: DGL is used in products positioned for upper-GI comfort and digestive wellness. The report highlights a 2025 randomized placebo-controlled GutGard clinical trial involving 200 participants, adding clinical evidence to the commercial positioning of standardized DGL ingredients.
- Increasing focus on glycyrrhizin control: Reducing glycyrrhizin is the defining feature of DGL. The report notes that Sabinsa lists its DGL ingredient at less than 3% glycyrrhizinic acid, illustrating the importance of low residual-glycyrrhizin specifications in commercial ingredient qualification.
- Regulatory and evidence development: In July 2026, the European Medicines Agency published a revised European Union herbal monograph and assessment package for licorice root. The report identifies stronger evidence, labeling and compositional control as important factors shaping demand quality.
Chemical Industry Pulse
The DGL market represents a specialized segment of the broader botanical-extract industry, where value depends increasingly on standardization, traceability and controlled processing rather than simply on raw-material volume. DGL manufacturers begin with Glycyrrhiza root and create commercial value through extraction, selective glycyrrhizin reduction, concentration, drying and standardization. Botanical origin, species, growing region, root age and post-harvest handling can influence the chemical profile of the final extract. This makes authenticated sourcing and analytical testing important for maintaining batch consistency. Commercial buyers also evaluate residual glycyrrhizin, heavy metals, microbiological quality and extract markers. The industry is simultaneously moving toward evidence-backed botanical ingredients, with branded standardized extracts using clinical research to differentiate from conventional licorice products. Multi-ingredient digestive-health formulations are also broadening the use of DGL beyond traditional stand-alone products.
Segmentation Highlights
- By Type: Pharmaceutical Grade, Food Grade, and Others. Pharmaceutical Grade carries the strictest specification environment because residual glycyrrhizin, contaminants and batch consistency are particularly important for medicinal applications.
- By Application: Food & Beverages, Nutraceuticals, and Pharmaceuticals. Nutraceuticals are a core commercial application, particularly for digestive-health products.
- By Region: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Regional Outlook
- Asia-Pacific: Asia-Pacific is the largest region in 2025 and leads through licorice processing, botanical-extract manufacturing and traditional-medicine supply chains. China and India are central to sourcing and ingredient production.
- North America: North America represents a mature digestive-health supplement market with demand for branded botanical ingredients. The report identifies DGL-labelled products in the NIH Dietary Supplement Label Database as a signal of active product and ingredient use.
- Europe: Europe combines established licorice use with formal herbal-medicine oversight. The July 2026 EMA revision of the European Union licorice-root monograph reinforces evidence and safety expectations for licorice-derived products.
- Latin America: Demand is driven by imported botanical ingredients used in supplements and functional formulations. Distributor relationships, documentation and finished-product registration influence market access.
- Middle East & Africa: The region includes licorice-growing and processing activity in Iran and nearby markets, while GCC and South African supplement channels provide downstream demand.
The report does not provide a complete percentage market-share breakdown for each region on the displayed page, so no unsupported regional percentages have been added.
Sample Report:
Competitive Landscape & Key Players
The DGL market consists primarily of specialized licorice extract manufacturers and botanical ingredient companies. The report profiles Jiangsu Tiansheng Pharmaceutical, Qinghai Lake Pharmaceutical, SA Herbal Bioactives, Natural Remedies, F&C Licorice Ltd., Zagros Licorice Co., and Maruzen Pharmaceuticals Co., Ltd. Natural Remedies differentiates through GutGard clinical studies, standardized flavonoids and finished-product pull-through. Jiangsu Tiansheng Pharmaceutical, Qinghai Lake Pharmaceutical, SA Herbal Bioactives and Maruzen compete through extraction capabilities, pharmaceutical or nutraceutical quality systems and proximity to botanical-processing ecosystems. F&C Licorice and Zagros Licorice focus on licorice-specific extraction expertise and raw-material access. Competition is shaped by authenticated sourcing, residual-glycyrrhizin control, clinical evidence, certifications, traceability and customer-specific standardization.
View the complete report as it is proper:
Frequently Asked Questions
- What is the current size of the DGL Market?
The global De-Glycyrrhizic Acid Licorice Extract Market was valued at USD 19.00 million in 2025 and is estimated at USD 19.86 million in 2026. - What is the forecast value by 2034?
The market is projected to reach USD 28.24 million by 2034, representing a 4.5% CAGR during 2026–2034. - Which application is most important?
Nutraceuticals are identified as a core commercial application, particularly for digestive-health formulations.
Report Scope
The De-Glycyrrhizic Acid Licorice Extract Market report covers DGL extract revenue and volume, Type and Application segmentation, regional sourcing and demand, botanical-feedstock economics, standardization, regulatory considerations, supplier positioning and recent market developments. The study defines the market boundary around standardized DGL extract ingredients rather than the full retail value of finished tablets, beverages or medicines. It examines Pharmaceutical Grade, Food Grade and Other grades, alongside Food & Beverages, Nutraceuticals and Pharmaceuticals applications. The research also addresses licorice-root sourcing, extraction, deglycyrrhizination, concentration, drying, standardization, residual-glycyrrhizin testing, botanical quality, safety, regulatory requirements, supplier positioning, clinical evidence and formulation development. The report covers 2025 as the base year, 2026 as the estimated year and 2034 as the forecast endpoint, with regional analysis across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
View the complete report as it is proper:
Download Sample Report:
Related Reports
About 24 Chemical Research
24 Chemical Research provides market intelligence and research covering chemicals, bio-based chemicals, botanical ingredients, materials and related industrial markets. Its research reports provide market sizing, forecasts, segmentation, regional analysis, competitive landscapes, company profiles, production and supply analysis, pricing, industry developments and market dynamics. Research coverage can include demand analysis, supply-side assessment, cost structures, company benchmarking, regional consumption, imports and exports, regulatory developments and strategic market opportunities.
Contact
24 Chemical Research
Asia: +91 9169162030
Email: help@24chemicalresearch.com
